期刊文献+

基于影像组学的头颈部鳞状细胞癌研究进展 被引量:2

Advances in head and neck squamous cell cancer research based on radiomics
原文传递
导出
摘要 头颈部鳞状细胞癌是世界上第六大常见恶性肿瘤[1]。尽管近年来头颈部鳞状细胞癌的手术治疗、放疗及化疗等方面取得了很大进展,但该疾病的5年生存率仍很低;而且不同的发病部位5年生存率差异较大,为25%(下咽癌)~60%(喉癌)[2-3]。超过50%的患者在就诊时已处于疾病晚期[3],此时病变累及广泛,只能选择根治性手术、同步放化疗,以及诱导化疗联合手术治疗等综合治疗手段。由于其部位和功能的特殊性,根治性切除手术亦或综合治疗可能导致头颈部功能的损害甚至丧失,如面容损毁,语言、呼吸以及咀嚼、吞咽功能障碍等,严重影响患者的生存质量[4]。 Radiomics refers to extract advanced quantitative features in radiological images in a high-throughput way,to invert the features into extensible data with the help of mathematical algorithms,and to establish descriptive and predictive models of tumors.It has important value in the diagnosis,treatment and prognosis of tumors.As an entirely new field,radiomics becomes the research hotspot of clinical medicine and biomedical engineering because of its objective,holistic,non-invasive characteristics.Head and neck squamous cell cancer is one of the common malignant tumors.Radiomics is gradually applied to the study of head and neck squamous cell cancer.This article reviews the research progress of radiomics and its application in head and neck cancer.
作者 董研博 张奥博 张金刚 刘良发 DONG Yanbo;ZHANG Aobo;ZHANG Jingang
出处 《临床耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2021年第2期181-184,共4页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
基金 中国科学院科研仪器专项“智能微相机阵列内窥成像系统研制”项目资助(No:YJKYYQ20180039)。
关键词 影像组学 头颈部肿瘤 鳞状细胞 成像 预测模型 radiomics head and neck neoplasms carcinoma squamous cell imaging predictive model
  • 相关文献

参考文献2

二级参考文献21

  • 1Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme [ J]. Science, 2008, 321 (5897) : 1807 - 1812.
  • 2Leu S, von Fehen S, Frank S, et al. Idh/mgmt-drlven molecular classification of low-grade glioma is a strong predictor for long-term survival [ J ]. Neuro Oncol, 2013, 15 (4) 469 - 479.
  • 3Wang YY, Zhang T, Li SW, et al. Mapping p53 mutations in low- grade glioma: A voxel-based neuroimaglng analysis [ J]. AJNR Am J Neuroradiol, 2015, 36(1): 70-76.
  • 4Houillier C, Wang X, Kaloshi G, et al. Idhl or idh2 mutations predict longer survival and response to temozolomide in low-grade gliomas [ J]. Neurology, 2010,75 (17) : 1560 - 1566.
  • 5Qi ST, Yu L, Lu YT, et al. Idh mutations occur frequently in chinese glioma patients and predict longer survival but not response to concomitant chemoradiotherapy in anaplastic gliomas [ J]. Oncol Rep, 2011,26(6) :1479 - 1485.
  • 6Hartmann C, Meyer J, Balss J, et al. Type and frequency of idhl and idh2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas [ J]. Acta Neuropathol, 2009, 118(4) : 469 -474.
  • 7Kim W, Liau LM. Idh mutations in human glioma [ J ]. Neurosurg Clin N Am, 2012, 23(3) : 471 -480.
  • 8Metellus P, Coulibaly B, Colin C, et al. Absence of idh mutation identifies a novel radiologic and molecular subtype of who grade ii gliomas with dismal prognosis [J]. Acta neuropathol, 2010, 120(6) : 719 -729.
  • 9Qi S, Yu L, Li H, et al, Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms [ J ]. Oncol Lett, 2014, 7 (6) : 1895 - 1902.
  • 10Sonoda Y, Shibahara I, Kawaguchi T, et al. Association between molecular alterations and tumor location and mri characteristics in anaplastic gliomas [ J]. Brain Tumor Pathol, 2015,32(2) : 99 -104.

共引文献63

同被引文献5

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部